Skip to content

Evaluation of the ruler with measurements of the cervix as a learning resource

Evaluation of the indicator of cervical dilatation as a didactic instrument

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-243frc
Enrollment
Unknown
Registered
2018-06-05
Start date
2018-06-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervix Uteri

Interventions

The population will have 80 students from the 5th and 7th semesters of obstetrics who will be allocated in two groups: 40 students in the control group - will verify cervical dilatation in the manikin
Device
Biological/vaccine
G08.686.784.769.326.500.080

Sponsors

Escola de Artes, Ciências e Humanidades da Universidade de São Paulo
Lead Sponsor
Escola de Artes, Ciências e Humanidades da Universidade de São Paulo
Collaborator

Eligibility

Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: To belong to the course of Obstetrics of the School of Arts, Sciences and Humanities of the University of São Paulo; be regularly enrolled in the 5th or 7th semester; not having completed the course Integrated Curricular Internship III (Assistance in childbirth and birth)

Exclusion criteria

Exclusion criteria: Have experience of the vaginal touch on the manikin; no agreement to participate in the study

Design outcomes

Primary

MeasureTime frame
The student affirms assertively the measurements of the uterine cervix in centimeters (1.5 cm to 9 cm) in the vaginal exam, in a manikin, verified through the use of the indicator rule of cervical dilatation, from the observation of a variation of at least 5% in the pre and post-intervention measurements

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactNatalucia Araujo

Escola de Artes, Ciências e Humanidades da Universidade de São Paulo

natalucia@usp.br+55-011-972488130

Outcome results

None listed

Source: REBEC (via WHO ICTRP)